KEWAUNEE SCIENTIFIC CORPORATION financials

  1. Home
  2. Financials
  3. KEQU
KEQU CIK 0000055529

Source: EDGAR filings · Built 2026-06-02T03:22:36Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 12.52M 15.10M -7.94M -9.79M -1.49M 1.70M
EBITDA 22.52M 21.41M 8.23M 161.00K 1.37M 309.00K
Working Capital 64.65M 56.04M 47.87M 49.27M 26.28M 27.17M
Net Debt 35.06M -12.27M 4.84M 5.01M 10.94M 4.83M
Gross Margin 28.63% 25.55% 16.21% 14.34% 16.27% 15.88%
Operating Margin 7.39% 8.97% 2.44% -1.54% -0.89% -1.59%
Net Margin 4.74% 9.20% 0.34% -3.63% -2.49% -3.18%
Return on Equity (ROE) 17.69% 34.25% 1.97% -17.16% -8.90% -12.20%
Return on Assets (ROA) 5.86% 13.92% 0.62% -5.16% -4.11% -5.58%
Current Ratio 2.20× 2.37× 2.20× 2.17× 1.77× 2.00×
Debt-to-Equity 0.78× 0.20× 0.35× 0.26× 0.39× 0.24×
Effective Tax Rate 21.66% -45.26% 69.79% -141.57% -37.83% -61.34%
Cash Conversion Ratio 1.30× 1.04× -5.14× 1.29× -0.25× -0.89×
Accruals Ratio -0.02× -0.01× 0.04× 0.01× -0.05× -0.11×
SBC % of Revenue 0.60% 0.50% 0.40% 0.43% 0.43% 0.17%
CapEx Coverage 6.52× 4.39× -0.91× -4.13× 0.38× 1.69×
Free Cash Flow Per Share $4.20 $5.14 $-2.74 $-3.52 $-0.54 $0.62

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 8.27× 5.60× 65.00× — — —
P/FCF 7.54× 6.94× — — — 16.59×
FCF Yield 13.27% 14.40% — — — 6.03%
EV / EBITDA 5.55× 4.16× 6.18× 278.21× 32.17× 106.70×
P/S 0.37× 0.50× 0.21× 0.24× 0.22× 0.19×
P/B 1.39× 1.85× 1.23× 1.11× 0.80× 0.73×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 240.47M 203.75M 219.49M 168.87M 147.47M 147.54M
Cost of Goods and Services Sold 171.62M 151.70M 183.91M 144.65M 123.48M 124.11M
Gross Profit 68.86M 52.05M 35.59M 24.22M 23.99M 23.43M
Research and Development Expense 919.00K 920.00K 1.01M 990.00K 1.41M 1.82M
Operating Expenses 51.10M 33.77M 30.22M 26.83M 25.31M 25.77M
Operating Income (Loss) 17.76M 18.28M 5.36M -2.61M -1.32M -2.35M
Income Tax Expense (Benefit) 3.20M -5.94M 3.14M 3.52M 990.00K 1.76M
Net Income (Loss) Attributable to Parent 11.40M 18.75M 738.00K -6.13M -3.67M -4.69M
Earnings Per Share, Basic $3.98 $6.51 $0.26 $-2.20 $-1.33 $-1.70
Weighted Average Number of Shares Outstanding, Basic 2.86M 2.88M 2.82M 2.79M 2.76M 2.75M
Earnings Per Share, Diluted $3.83 $6.38 $0.25 $-2.20 $-1.33 $-1.70
Weighted Average Number of Shares Outstanding, Diluted 2.98M 2.94M 2.90M 2.79M 2.76M 2.75M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 14.94M 23.27M 8.08M 4.43M 5.21M 4.37M
Assets, Current 118.36M 96.82M 87.92M 91.56M 60.46M 54.23M
Assets 194.65M 134.77M 118.90M 118.77M 89.38M 83.93M
Long-term Debt 37.69M — — — — 0
Liabilities, Current 53.71M 40.78M 40.05M 42.29M 34.18M 27.06M
Long-term Debt, Excluding Current Maturities 34.69M — — — — —
Liabilities 128.41M 78.56M 80.41M 82.59M 47.90M 45.23M
Stockholders' Equity Attributable to Parent 64.46M 54.76M 37.41M 35.69M 41.24M 38.41M
Common Stock, Shares, Outstanding 2.84M 2.84M 2.83M 2.79M 2.76M 2.75M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 14.78M 19.56M -3.79M -7.88M 912.00K 4.16M
Net Cash Provided by (Used in) Investing Activities -30.90M -4.37M -4.15M -1.91M -2.40M -2.46M
Payments for Repurchase of Common Stock 1.60M 2.00M 0 — — —
Net Cash Provided by (Used in) Financing Activities 7.41M -3.01M 14.93M 11.03M 1.98M -7.46M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (KEQU CIK 0000055529), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

FTV

Fortive Corp

PKBK

PARKE BANCORP, INC.

ALDX

ALDEYRA THERAPEUTICS, INC.